Revium Recovery Inc (RVRC PINK) stock market data APIs
$1.6731
0(0%)
as of May 15, 2026
Try our APIs with
free plan!
Revium Recovery Inc Financial Data Overview
Price chart is built with
Anychart
Revium Rx. operates as a pre-clinical stage biopharmaceutical company focused on the development of nanoparticle-based therapies in the United States. The company develops lipid-based platforms for a variety of uses including antimicrobial resistance and solid tumors; specializes in infectious diseases, including antibiotic-resistant infections, solid tumors, and vaccination; and develops nano-liposomal particles (NLP) based pharmaceutical candidates. It also offers Nano-Mupirocin, a NLP-based formulation of potent antibiotic mupirocin. In addition, the company develops nanoparticles-based formulation of an angiotensin receptor blockers; novel adjunct for cancer therapies: and novel immunization based on liposomal protein-loaded technology. The company was formerly known as Revium Recovery Inc. and changed its name to Revium Rx. in December 2024. Revium Rx. was incorporated in 1997 and is headquartered in Herzliya, Israel.
Prev. Close
1.6731
Open
1.6731
High
1.6731
Low
1.6731
52 wk Range
0.5-1.67
Market Cap
101 M
Shares Outstanding
60 729 K
Revenue
11 393
EPS
-0.0171
Beta
-0.801
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Revium Recovery Inc data using free add-ons & libraries
Get Revium Recovery Inc Fundamental Data
Revium Recovery Inc Fundamental data includes:
- Net Revenue: 11 393
- EBITDA: -3 459 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-06-30
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Revium Recovery Inc News
New
May 2026's European Undervalued Small Caps With Insider Buying
In recent weeks, the European market has shown modest gains amid easing geopolitical tensions and robust corporate earnings, although potential tariff threats from the U.S. have introduced some volati...
3 European Stocks Estimated To Be Trading Up To 46.5% Below Intrinsic Value
As European markets experience a rally, buoyed by geopolitical developments such as the U.S.-Iran ceasefire and subsequent investor optimism, there is a renewed focus on identifying stocks that may be...
European Market: 3 Stocks Conceivably Trading Below Estimated Value
The European market has recently faced renewed trade and geopolitical uncertainties, leading to a decline in major stock indexes such as the STOXX Europe 600, France's CAC 40, and Germany's DAX. Despi...
Undiscovered Gems in Europe for November 2025
As European markets navigate a landscape marked by cooling sentiment on artificial intelligence and mixed economic indicators, the pan-European STOXX Europe 600 Index has shown resilience with a 1.77%...
Get Revium Recovery Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
